ST
CBPO

Smithfield Trust’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Smithfield Trust’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-499
Closed -$56K – 849
2017
Q2 		$56K Sell
499
-71
-12% -$7.93K 0.01% 506
2017
Q1 		$57K Sell
570
-30
-5% -$3.21K 0.01% 500
2016
Q4 		$65K Buy
600
+201
+50% +$23.5K 0.01% 465
2016
Q3 		$49K Buy
+399
New +$47.1K 0.01% 513

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

Smithfield Trust's CBPO Position: Q3 2017 in Review

Smithfield Trust sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2017, closing a stake of 499 shares — an estimated $56K sold.

Smithfield Trust first reported a position in CBPO in Q3 2016 and held it in 4 quarters. The position peaked at $65K in Q4 2016. 94 funds tracked by Wall St. Rank hold CBPO as of Q3 2017.

  • Smithfield Trust reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2017 after selling out during the quarter.
  • Smithfield Trust sold 499 China Biologic Products Holdings, Inc. shares in Q3 2017, an estimated $56K.
  • Smithfield Trust first reported a position in China Biologic Products Holdings, Inc. in Q3 2016 and held it in 4 quarters.
  • Smithfield Trust's China Biologic Products Holdings, Inc. position peaked at $65K in Q4 2016.
  • 94 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2017.

Based on Smithfield Trust's 13F filing for Q3 2017, filed 3 Nov 2017.